Skip to content

Pharminent

Primary Menu
  • Home
    • Pro Hub
Light/Dark Button
Hub
  • Home
  • Regulatory
  • FDA posts new rejection letters days after confirming pause
  • Regulatory

FDA posts new rejection letters days after confirming pause

BioSpace

The FDA last week confirmed that it would suspend the release of complete response letters pending the resolution of a citizen petition from an unnamed pharma company.

Read full story

pharminent July 13, 2026 (Last updated: July 14, 2026)

BioSpace

The FDA last week confirmed that it would suspend the release of complete response letters pending the resolution of a citizen petition from an unnamed pharma company.

Read full story

Post navigation

Previous: “Hub-and-spoke” drug manufacturing set to benefit from new FDA rule
Next: Major trial launched to explore GLP-1 benefit in dementia

Related Stories

  • Regulatory

Bayer’s Hyrnuo set for the NSCLC frontlines on accelerated FDA label expansion

pharminent September 10, 2026
  • Regulatory

HHS appoints permanent FDA CBER, CDER heads

pharminent September 10, 2026
  • Regulatory

FDA approves AstraZeneca’s Etcamah combo for advanced breast cancer

pharminent September 7, 2026
  • Home
  • Contact
© 2026 All rights reserved. | ReviewNews by AF themes.